JGJúlia Lenza Goulart

Júlia Lenza Goulart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Júlia Lenza Goulart has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    High likelihood of obstructive sleep apnea and associated factors among road freight transport workers in Brazil

    by Júlia Lenza Goulart, Heloísa Silva Guerra, Carlabianca Cabral de Jesus Canevari, Elton Brás Camargo Júnior, Fábio Vieira de Andrade Borges, Anderson Garcez, Renato Canevari Dutra da Silva

  • Open Access

    Demystifying the results obtained through the use of SGLT-2 inhibitor drugs, used by patients at the Reference Center for Hypertension and Diabetes Rio Verde - Goiás

    by Luan Queiroz Fernandes Pereira, Thamires Ferreira dos Santos, Rodrigo Jacques da Silva, Hortência Thales Padilha Gomes, Júlia Lenza Goulart, João Felipe Cardoso Carvalho, Lucas Almeida Azevedo Carlos

    Introduction: Due to the increase in glucose excretion of renal sodium-glucose cotransporter 2 (ISGLT-2) inhibitors, there is also a reduction in weight through its glycosuric effect. Objective: To analyze the efficacy of ISGLT-2 based on medical records and glycemic levels according to glycated blood glucose; to verify which medications are most prescribed and to observe poor adherence due to side effects in patients of the CRHD in Rio Verde-GO. Methods: A descriptive observational study was carried out using the medical records of diabetic patients treated at the CRHD as the main means of data collection, identifying and comparing laboratory values based on the different pharmacological conducts performed. And manually organize and group the search results on the Excel platform, where they will later be converted into easy-to-view graphs for the public. Results And Discussion: When analyzing the glycated hemoglobin (HbA1c) of the patients before and after the introduction of the ISGLT-2 class, it was noted that 80% obtained a laboratory improvement and 20% a worsening. The results reveal that 80% had an improvement in glycated hemoglobin, as they presented good adherence to the medication and specific and balanced nutrition for their condition. Conclusion: There is an improvement in glycated hemoglobin in most of the patients treated at the CRHD who are users of iSGLT-2, where the most used medication is Forxiga (Dapaglifozin), which is part of the medications of the SUS network.

  • Open Access

    Análise da prescrição medicamentosa dos idosos atendidos em um ambulatório de geriatria

    by Letícia Kelly de Macedo Vaz, André Santos Pereira Ramos, Julia Lenza Goulart, Tercio Carneiro Ramos, Maria Emilia Santos Pereira Ramos

    OBJETIVO: Avaliar a prescrição medicamentosa dos idosos atendidos em um ambulatório geriátrico baseado Consenso Brasileiro de Medicamentos Potencialmente Inapropriados para Idosos (MPI). METODOLOGIA: Trata-se de uma pesquisa descritiva com análise retrospectiva do prontuário eletrônico de pacientes com idade igual ou superior a 60 anos, atendidos no ambulatório geriátrico de um hospital baiano no período de janeiro a junho de 2018. Foram incluídos 291 prontuários e coletados os medicamentos que o idoso já fazia uso em seu domicílio e a prescrição vigente após a consulta. RESULTADOS: A idade mediana foi de 73 anos. Foi identificado que antes da consulta 89 idosos (30,6%) faziam uso de MPI e que após a consulta com geriatra 110 idosos (37,6%) passaram a utilizá-los, sem diferença estatística. A mediana de números de medicamentos posteriores à consulta ambulatorial foi maior do que anterior à consulta, com significância estatística (pCONCLUSÃO: Mesmo após a consulta com o geriatra ainda existem inadequações nas prescrições, com um número relevante de idosos utilizando cinco ou mais medicamentos e em uso de MPI.